LKTime Biotech | End-to-End & One-Stop CDMO Services for Biologics

Company Profile

Specializing in Biologics CDMO Services!

Lktime Biotechnology CO., Ltd. (“Lktime Biotech” for short) established in June 2021, is a high-tech enterprise specializing in CDMO services for biopharmaceutical products. The company has established R&D and pilot-scale platforms in Fengxian Lin-gang and Zhangjiang, Shanghai, as well as is building a commercial production base in Cuiheng New District, Zhongshan City.

Lktime Biotech is dedicated to building a leading domestic and international biologics CDMO service platform, aiming to offer biopharmaceutical innovative companies with services including druggability evaluation, high-quality early pharmacology/toxicology research sample production, production process development, clinical registration application services, clinical sample production and commercial manufacturing. All services are provided leveraging mammalian cell platform and microbial platform as the core technology platforms.

Lktime Biotech’s one-stop CDMO services can accelerate preclinical development of biologics, improve the quality of biological products and reduce manufacturing costs for our clients. This will enable our clients to launch better quality and more affordable biopharmaceuticals to market sooner!

R&D Center

Production Centers

50 +

Projects

100 +

Staff

Three Centers

R&D Center in Fengxian District, Shanghai

It can provide preclinical R&D services and phase Ⅰ/Ⅱ clinical sample manufacturing services.

Total area: 5300㎡.

The center is equipped with 200L×2 GMP production facilities for mammalian cell expression and 500L×1 production facility for microbial expression.

The center can meet the production requirements for early clinical samples (vial, prefilled syringe, cartridge).

Pilot-scale production base in Zhangjiang, Shanghai

Total area: 1500㎡

The base is equipped with a 2000L×1 advanced production facility (from Sartorius, Cytiva, Merck) for mammalian cell expression.

Commercial production base in Cuiheng, Zhongshan

The base can provide key clinical sample production and commercial production services.

Phase I of the base will feature one 1,500L and one 7,500L GMP production facility for microbial expression, as well as 2,000L × 2 GMP production facilities for CHO cell expression.

The base can meet the production requirements for clinical samples (vial, prefilled syringe, cartridge).

MISSION

Our mission is to enable pharmaceutical companies to launch higher quality and more affordable biologics to market sooner.

PHILOSOPHY

Our philosophy is to be your most trustworthy one-stop biologics CDMO partner.